Factors Influencing Discussion of Cancer Genetic Testing with Health-Care Providers in a Population-Based Survey.

ABSTRACT:

Introduction

Discussion of cancer genetic testing with health-care providers (HCPs) is necessary to undergo testing to inform cancer risk assessment and prevention. Given the rapid evolution in genetic testing practice in oncology, we describe the current landscape of population-level cancer genetic testing behaviors.

Methods

A questionnaire including items regarding discussion of cancer genetic testing with HCPs was administered to a nonprobability sample (N = 2,029) of the Texas population.

Results

Overall, 11% of respondents discussed cancer genetic testing with HCPs. In multivariable analysis, discussion was significantly related to having a personal history of breast/ovarian/colon cancer (OR = 11.57, 95% CI = 5.34-25.03), personal history of other cancer (OR = 3.

SUBMITTER: Makhnoon S 

PROVIDER: S-EPMC8355036 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature